Search filters

List of works by Andrew M Tershakovec

Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT.

scientific article published on September 2015

Achieving goal lipid levels with ezetimibe plus statin add-on or switch therapy compared with doubling the statin dose. A pooled analysis

scientific article published on 4 November 2014

Competing Risks of Cardiovascular Versus Noncardiovascular Death During Long-Term Follow-Up After Acute Coronary Syndromes

scientific article published on 18 September 2017

Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: final baseline characteristics of the IMPROVE-IT study population

scientific article published on 15 May 2014

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes

scientific article

Long-term Safety and Efficacy of Achieving Very Low Levels of Low-Density Lipoprotein Cholesterol : A Prespecified Analysis of the IMPROVE-IT Trial

scientific article published on 14 March 2017

Medication Discontinuation in the IMPROVE-IT Trial

scientific article published on 01 January 2019

Natural History of Patients Postacute Coronary Syndrome Based on Heart Failure Status

scientific article published on 04 August 2018

On-treatment analysis of the Improved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT).

scientific article published on 23 September 2016

Prevention of Stroke with the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial).

scientific article published on 30 September 2017

Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome: The IMPROVE-IT Trial

scientific article published on February 2016